227 related articles for article (PubMed ID: 34840594)
21. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Sun Y; Zhang F; Wang L; Song X; Jing J; Zhang F; Yu S; Liu H
Mol Med Rep; 2019 Jun; 19(6):5237-5250. PubMed ID: 31059056
[TBL] [Abstract][Full Text] [Related]
22. Identification of a Genomic Instability-Related Long Noncoding RNA Prognostic Model in Colorectal Cancer Based on Bioinformatic Analysis.
Liang Y; Sun HX; Ma B; Meng QK
Dis Markers; 2022; 2022():4556585. PubMed ID: 35711569
[TBL] [Abstract][Full Text] [Related]
23. A New Prognostic Strategy Based on four DNA Repair-Associated lncRNAs for Hepatocellular Carcinoma.
Zeng H; Liu C; Zhou X; Liu L
Comb Chem High Throughput Screen; 2022; 25(5):906-918. PubMed ID: 33653241
[TBL] [Abstract][Full Text] [Related]
24. Construction of a long non-coding RNA-associated ceRNA network reveals potential prognostic lncRNA biomarkers in hepatocellular carcinoma.
Yan Y; Yu J; Liu H; Guo S; Zhang Y; Ye Y; Xu L; Ming L
Pathol Res Pract; 2018 Dec; 214(12):2031-2038. PubMed ID: 30316688
[TBL] [Abstract][Full Text] [Related]
25. A four-long noncoding RNA signature predicts survival of hepatocellular carcinoma patients.
Jiang H; Zhao L; Chen Y; Sun L
J Clin Lab Anal; 2020 Sep; 34(9):e23377. PubMed ID: 32474975
[TBL] [Abstract][Full Text] [Related]
26. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract][Full Text] [Related]
27. Computational detection of a genome instability-derived lncRNA signature for predicting the clinical outcome of lung adenocarcinoma.
Guo CR; Mao Y; Jiang F; Juan CX; Zhou GP; Li N
Cancer Med; 2022 Feb; 11(3):864-879. PubMed ID: 34866362
[TBL] [Abstract][Full Text] [Related]
28. Identification and development of TP53 mutation-associated Long non-coding RNAs signature for optimized prognosis assessment and treatment selection in hepatocellular carcinoma.
Chu C; Liu D; Wang D; Hu S; Zhang Y
Int J Immunopathol Pharmacol; 2023; 37():3946320231211795. PubMed ID: 37942552
[TBL] [Abstract][Full Text] [Related]
29. Genomewide identification of a novel six-LncRNA signature to improve prognosis prediction in resectable hepatocellular carcinoma.
Wu Y; Wang PS; Wang BG; Xu L; Fang WX; Che XF; Qu XJ; Liu YP; Li Z
Cancer Med; 2018 Dec; 7(12):6219-6233. PubMed ID: 30378276
[TBL] [Abstract][Full Text] [Related]
30. Four long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
Wang J; Pu J; Yao T; Lu X; Deng Y
J Cell Physiol; 2019 Jun; 234(6):8709-8716. PubMed ID: 30417366
[TBL] [Abstract][Full Text] [Related]
31. Genome instability-related long non-coding RNA in clear renal cell carcinoma determined using computational biology.
Wang Y; Yan K; Wang L; Bi J
BMC Cancer; 2021 Jun; 21(1):727. PubMed ID: 34167490
[TBL] [Abstract][Full Text] [Related]
32. Identification of aberrantly expressed lncRNA and the associated TF-mRNA network in hepatocellular carcinoma.
Wang B; Tang D; Zhang Z; Wang Z
J Cell Biochem; 2020 Feb; 121(2):1491-1503. PubMed ID: 31498488
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive Analyses of Mutation-Derived Long-Chain Noncoding RNA Signatures of Genome Instability in Kidney Renal Papillary Cell Carcinoma.
Li J; Wei S; Zhang Y; Lu S; Zhang X; Wang Q; Yan J; Yang S; Chen L; Liu Y; Huang Z
Front Genet; 2022; 13():874673. PubMed ID: 35547247
[No Abstract] [Full Text] [Related]
35. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
36. Mutator-Derived lncRNA Landscape: A Novel Insight Into the Genomic Instability of Prostate Cancer.
Tang L; Li W; Xu H; Zheng X; Qiu S; He W; Wei Q; Ai J; Yang L; Liu J
Front Oncol; 2022; 12():876531. PubMed ID: 35860569
[TBL] [Abstract][Full Text] [Related]
37. Long non‑coding RNA‑based risk scoring system predicts prognosis of alcohol‑related hepatocellular carcinoma.
Luo Y; Ye J; Wei J; Zhang J; Li Y
Mol Med Rep; 2020 Aug; 22(2):997-1007. PubMed ID: 32468063
[TBL] [Abstract][Full Text] [Related]
38. Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma.
Ma Y; Luo T; Dong D; Wu X; Wang Y
Gene; 2018 Jul; 663():148-156. PubMed ID: 29684484
[TBL] [Abstract][Full Text] [Related]
39. A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma.
Yang H; Zhang W; Ding J; Hu J; Sun Y; Peng W; Chu Y; Xie L; Mei Z; Shao Z; Xiao Y
Front Immunol; 2022; 13():970588. PubMed ID: 36148233
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of an immune-related ceRNA network in identifying a novel lncRNA signature as a prognostic biomarker for hepatocellular carcinoma.
Chen R; Chen Y; Huang W; Zhao Y; Luo W; Lin J; Wang Z; Yang J
Aging (Albany NY); 2021 Jul; 13(13):17607-17628. PubMed ID: 34237706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
